[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.159.27. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
June 10, 1992

Secretory Otitis Media: The Cantekin Affair-Reply

Author Affiliations

American Medical Association Chicago, Ill

JAMA. 1992;267(22):3031. doi:10.1001/jama.1992.03480220047025
Abstract

In Reply.  —Drs Gates and Klein accuse me of "emphasizing the sensational and personal aspects rather than the science of the dispute." They ignore the obvious fact that our readers require explanation as to why we are taking the exceptional step of publishing a reanalysis of the trial data and the extraordinary one of doing so 6 years later. It should be clear that the reasons were not merely scientific, and I could not have properly focused on the "problems related to peer review and publication" without recording the nature of those problems. The other achievements of the Pittsburgh group, which JAMA has recognized by publishing their recent work,1,2 are not at issue.Readers of Mandel et al3 will look in vain for any acknowledgment concerning Bluestone's "honoraria and grant support from pharmaceutical companies" so the statement by Gates and Klein that these were "identified" is astonishing. The

×